A prognostic model derived from PANoptosis-associated subtypes unveils immunological features and therapeutic vulnerabilities in cervical cancer
This study establishes a PANoptosis-derived prognostic model with moderate but consistent prognostic utility across platforms, underscoring its potential research value. By linking PRGs to risk stratification and immune heterogeneity, the model provides insights into PANoptosis biology and supports future exploration of personalized immunotherapy in cervical cancer.
Authors
- Keke Zhang (ORCID: https://orcid.org/0000-0002-5755-7059)
- Lili Xu (ORCID: https://orcid.org/0000-0003-4858-0828)
- Yao Li (ORCID: https://orcid.org/0000-0001-8289-8181)
- Yuehong Tong (ORCID: https://orcid.org/0009-0008-5057-8077)
- Wei Deng (ORCID: https://orcid.org/0009-0002-7817-1662)
Institutions
- Jingzhou Maternal and Child Health Hospital (CN)
- Jinhua Central Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-11-22
- DOI
- https://doi.org/10.1007/s12672-025-04115-5
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00